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KEYWORD Summary In this report, we discuss the case of a male neonate who underwent
Necrotizing pneumonia surgical correction for coarctation of the aorta. The recovery of this patient was
complicated by postsurgical necrotizing pneumonitis that resolved completely after
a prolonged hospital stay with recurrent deterioration.
© 2013 King Saud Bin Abdulaziz University for Health Sciences. Published by Elsevier
.
cLtd. All rights reserved
IntroductionNecrotizing pneumonia (NP), also called mas-
sive pulmonary gangrene, is a known form of
Abbreviations: CoA, coarctation of the aorta; PDA, patent
ductus arteriosus; NCPAP, nasal continuous positive airway pres-
sure; ETT, endotracheal tube; WBCs, white blood cells; DIC,
disseminated intravascular coagulopathy; CT, computed tomo-
graphy; NP, necrotizing pneumonia; VAP, ventilator-associated
pneumonia; MRSA, methicillin-resistant Staphylococcus aureus;
P. aeruginosa, Pseudomonas aeruginosa.
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http://dx.doi.org/10.1016/j.jiph.2012.11.007omplicated pneumonia that typically affects
mmunocompetent individuals with no risk fac-
ors. This condition has been rarely reported in
eonates. Therefore, we present our neonatal case
f NP following the surgical repair of congenital
eart defects.
ase summary
full-term baby boy born to a healthy mother
resented to a community hospital at 9 days of
ge with heart failure secondary to coarctation
f the aorta (CoA) and patent ductus arteriosus
PDA), which was managed with prostaglandins and
Sciences. Published by Elsevier Ltd. All rights reserved.
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Figure 1 (A) A frontal chest X-ray at the age of 43 days shows hazy opacity in the left upper lobe consistent with
pneumonia. (B) A chest CT (without contrast) image at 44 days of age shows multiple parenchymal cystic lesions in
the left upper lobe consistent with the diagnosis of multifocal necrotizing pneumonia. (C) A chest CT (with contrast)
image, axial view, taken post-therapy at 60 days of age shows complete resolution of the necrotizing pneumonia. (D)
A follow-up frontal chest X-ray (at the age of 3 months) after the treatment course showing complete resolution of
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the left upper lobe multifocal necrotizing pneumonia.
equired invasive ventilation. During his hospital
tay, there were no complications and no require-
ent for antibiotics. He was transferred to our
nstitute for surgical repair at 17 days of age.
pon arrival, he was hypotensive secondary to his
ardiac defects, and this condition was managed
onservatively until surgery. Surgical correction of
he CoA and ligation of the PDA were performed
t 19 days of age. After the surgery, the patient
emained ventilated, and peritoneal dialysis was
nitiated because of relative acute renal failure that
eveloped preoperatively secondary to his heart
ondition. He remained ventilated for two days and
as then extubated to nasal continuous positive
irway pressure (NCPAP). His serial chest X-rays
rom admission until 24 days of age showed an
ncrease in haziness on the right side that did not
equire intervention because of the stability of his
ondition. At 24 days of age, his respiratory sta-
us deteriorated, with signiﬁcant desaturation and
cute hypercapnic respiratory failure that required
ntubation and ventilation. Subsequently, his clini-
al condition deteriorated, with evidence of septic
e
p
o
ehock, disseminated intravascular coagulopathy
DIC) and leucopenia (white blood cell (WBC) count,
900/mm3). He was started on broad-spectrum
ntibiotics. An endotracheal tube (ETT) culture
rew Pseudomonas aeruginosa and methicillin-
esistant Staphylococcus aureus (MRSA); therefore,
he antibiotics were changed to vancomycin and
eropenem for a total of ten days. He remained
table for an additional six days and was extubated
uccessfully to NCPAP, with signiﬁcant improve-
ent in right lung aeration. Subsequently, he
eveloped P. aeruginosa bacteremia and respira-
ory distress that required re-intubation. He was
nitially treated with ceftazidime, amikacin and
loxacillin and was later treated with meropenem.
epeated ETT cultures at 41 days of age grew
tenotrophomonas maltophilia in addition to P.
eruginosa. Meropenem was administered at that
ime. His clinical condition improved, and he was
xtubated at 44 days of age. Computed tomogra-
hy (CT) of his chest was performed at 44 days
f age and showed multifocal patchy airspace dis-
ase in the right upper and lower lobes and soft
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tissue density in the anterior segment of the left
upper lobe with air lucency suggestive of NP (Fig. 1A
and B). He remained stable until 46 days of age,
when he again developed respiratory distress and
required re-intubation and supportive mechanical
ventilation. His ETT culture grew P. aeruginosa
and Enterobacter cloaca, and thus, the patient
was treated with tazocine and vancomycin for ten
days. He was then extubated and maintained on
NCPAP for two days. He maintained saturation with
supportive oxygen at 2 l/min via a nasal cannula.
Repeated CT of the chest at 60 days of age showed
signiﬁcant improvement with near complete reso-
lution of the multifocal air space disease (Fig. 1C).
The patient was moved to the cardiac step-down
ward for observation until 65 days of age and was
then transferred in a stable condition to his pri-
mary hospital after a total of 51 days of admission.
A follow-up chest X-ray at 3 months of age showed
marked improvement in the lung ﬁelds (Fig. 1D).
Discussion
Ventilator-associated pneumonia (VAP) is consid-
ered the second most common hospital-acquired
infection among pediatric intensive care unit
patients, and many risk factors contribute to the
development of this disease [1]. Cardiac surgery
is considered an important risk factor for VAP [2]
and is an important contributing factor to morbid-
ity and mortality associated with VAP, which are
highly associated with the complexity of the cardiac
disease [2].
VAP following cardiac surgery has been studied
extensively in the adult population, but there have
been few studies of VAP among pediatric patients
following cardiac surgery speciﬁcally [2]. The rate
of VAP post-cardiac surgery in the pediatric pop-
ulation varies between 8.8% and 21.5%, and the
majority of these cases have been reported in
infants [3].
Necrotizing pneumonia typically occurs as a com-
plication of community-acquired pneumonia [6,7].
Furthermore, neonates are not part of the age
group that typically develops NP. To our knowledge,
only three neonates with NP have been reported:
a preterm infant who was 2 weeks old [4] and a
pair of twins [5]. However, none of those infections
occurred following cardiac surgery. NP typically
affects immunocompetent individuals with no risk
factors, and the usual presentation is fever with
constitutional symptoms [6]. NP is primarily caused
by Streptococcus pneumonia, community-acquired
MRSA and other organisms [7]. Additionally, NP is
typically caused by a single organism, but it can beR.S. Al Tassan et al.
aused by multiple organisms in the adult popula-
ion [7—9]. Although the WBC count is not known
o be predictive of the occurrence or severity of
P based on the reported cases, leucopenia in
atients with NP caused by MRSA has been reported
y some authors to be related to bacterial toxins
hat directly lyse neutrophils. Some authors have
eported that neutropenia is a severity factor that
an affect prognosis [10,11]. Regarding the man-
gement of NP, there are no evidence-based data
o guide the choice of antibiotics, and the choice
f antibiotics is dependent on the clinical situa-
ion in individual cases. Surgical intervention may
e required [9—12]. The typical duration of hospi-
alization is up to 2—3 months [10]. Although the
utcome of community-acquired NP in the adult
opulation is generally poor and although this dis-
ase is associated with high morbidity and mortality
ates, the situation is different in the pediatric
opulation, in which NP is generally associated
ith a favorable outcome; however, there are no
upporting data regarding the outcome of hospital-
cquired NP [6,11].
To our knowledge, our case is the ﬁrst to
e reported in the literature. Our patient was
neonate who developed VAP following cardiac
urgery, which was complicated by NP caused by
ultiple organisms. The patient received mul-
iple antibiotic courses and required prolonged
ospitalization, which ended with a favorable
utcome.
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